Number | 1stassessment after cycles 1-4 | 2ndassessment after cycles 5-8 | Bevacizumab maintaining times | Radiotherapy (Gy) | 3rdassessment |
---|---|---|---|---|---|
1 | CRu | CR | 0 | 40.6 | CR |
2 | CRu | CR | 7 | 40 | CR |
3 | CRu | CR | 7 | 36 | CR |
4 | PD | NAa | 0 | No | NA |
5 | CRu | CR | 6 | 42 | CR |
6 | CRu | CR | 4 | 42 | CR |
7 | PR | CRu | 0 | 50 | CR |